Circadian variability of insulin sensitivity: Physiological input for in silico artificial pancreas

Roberto Visentin, Chiara Dalla Man, Yogish C Kudva, Ananda Basu, Claudio Cobelli

Research output: Contribution to journalArticle

39 Citations (Scopus)

Abstract

Closed-loop control clinical research trials have been considerably accelerated by in silico trials using the Food and Drug Administration-accepted type 1 diabetes mellitus (T1DM) simulator. We have recently demonstrated that postprandial insulin sensitivity (SI) in T1DM subjects was lower at breakfast (B) than lunch (L) and dinner (D), but not significantly, because of the small population size. The goal of this study was therefore to incorporate this novel information into the University of Virginia/Padova T1DM simulator and to reproduce in silico the observed circadian variability. Twenty T1DM subjects received an identical mixed meal at B, L, and D. SI was calculated for each meal using the oral glucose minimal model. Seven SI daily patterns were identified, and their probabilities were estimated. Each in silico subject was linked to a time-varying SI profile, while random deviations of up to 40% were allowed. Simulations were compared with experimental data. The integrated area above the basal glucose curve values were 2.60±0.91 (B), 1.38±0.91 (L), and 1.44±1.07 (D) 104 min·mg/dL in silico versus 2.87±1.65 (B), 1.98±1.56 (L), and 2.16±2.00 (D) 104 min·mg/dL in vivo. Incremental peak glucose values were 109±33 (B), 80±29 (L), and 81±30 (D) mg/dL in silico versus 136±39 (B), 126±37 (L), and 125±48 (D) mg/dL in vivo. The incorporation of a time-varying SI into the simulator makes this technology suitable for running multiple-meal scenarios, thus enabling a more robust design of artificial pancreas algorithms.

Original languageEnglish (US)
Pages (from-to)1-7
Number of pages7
JournalDiabetes Technology and Therapeutics
Volume17
Issue number1
DOIs
StatePublished - Jan 1 2015

Fingerprint

Artificial Pancreas
Computer Simulation
Insulin Resistance
Type 1 Diabetes Mellitus
Meals
Glucose
Lunch
Breakfast
United States Food and Drug Administration
Population Density
Clinical Trials
Technology
Research

ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism
  • Medical Laboratory Technology

Cite this

Circadian variability of insulin sensitivity : Physiological input for in silico artificial pancreas. / Visentin, Roberto; Dalla Man, Chiara; Kudva, Yogish C; Basu, Ananda; Cobelli, Claudio.

In: Diabetes Technology and Therapeutics, Vol. 17, No. 1, 01.01.2015, p. 1-7.

Research output: Contribution to journalArticle

Visentin, Roberto ; Dalla Man, Chiara ; Kudva, Yogish C ; Basu, Ananda ; Cobelli, Claudio. / Circadian variability of insulin sensitivity : Physiological input for in silico artificial pancreas. In: Diabetes Technology and Therapeutics. 2015 ; Vol. 17, No. 1. pp. 1-7.
@article{d91db58ae37241829661ff1771ac38db,
title = "Circadian variability of insulin sensitivity: Physiological input for in silico artificial pancreas",
abstract = "Closed-loop control clinical research trials have been considerably accelerated by in silico trials using the Food and Drug Administration-accepted type 1 diabetes mellitus (T1DM) simulator. We have recently demonstrated that postprandial insulin sensitivity (SI) in T1DM subjects was lower at breakfast (B) than lunch (L) and dinner (D), but not significantly, because of the small population size. The goal of this study was therefore to incorporate this novel information into the University of Virginia/Padova T1DM simulator and to reproduce in silico the observed circadian variability. Twenty T1DM subjects received an identical mixed meal at B, L, and D. SI was calculated for each meal using the oral glucose minimal model. Seven SI daily patterns were identified, and their probabilities were estimated. Each in silico subject was linked to a time-varying SI profile, while random deviations of up to 40{\%} were allowed. Simulations were compared with experimental data. The integrated area above the basal glucose curve values were 2.60±0.91 (B), 1.38±0.91 (L), and 1.44±1.07 (D) 104 min·mg/dL in silico versus 2.87±1.65 (B), 1.98±1.56 (L), and 2.16±2.00 (D) 104 min·mg/dL in vivo. Incremental peak glucose values were 109±33 (B), 80±29 (L), and 81±30 (D) mg/dL in silico versus 136±39 (B), 126±37 (L), and 125±48 (D) mg/dL in vivo. The incorporation of a time-varying SI into the simulator makes this technology suitable for running multiple-meal scenarios, thus enabling a more robust design of artificial pancreas algorithms.",
author = "Roberto Visentin and {Dalla Man}, Chiara and Kudva, {Yogish C} and Ananda Basu and Claudio Cobelli",
year = "2015",
month = "1",
day = "1",
doi = "10.1089/dia.2014.0192",
language = "English (US)",
volume = "17",
pages = "1--7",
journal = "Diabetes Technology and Therapeutics",
issn = "1520-9156",
publisher = "Mary Ann Liebert Inc.",
number = "1",

}

TY - JOUR

T1 - Circadian variability of insulin sensitivity

T2 - Physiological input for in silico artificial pancreas

AU - Visentin, Roberto

AU - Dalla Man, Chiara

AU - Kudva, Yogish C

AU - Basu, Ananda

AU - Cobelli, Claudio

PY - 2015/1/1

Y1 - 2015/1/1

N2 - Closed-loop control clinical research trials have been considerably accelerated by in silico trials using the Food and Drug Administration-accepted type 1 diabetes mellitus (T1DM) simulator. We have recently demonstrated that postprandial insulin sensitivity (SI) in T1DM subjects was lower at breakfast (B) than lunch (L) and dinner (D), but not significantly, because of the small population size. The goal of this study was therefore to incorporate this novel information into the University of Virginia/Padova T1DM simulator and to reproduce in silico the observed circadian variability. Twenty T1DM subjects received an identical mixed meal at B, L, and D. SI was calculated for each meal using the oral glucose minimal model. Seven SI daily patterns were identified, and their probabilities were estimated. Each in silico subject was linked to a time-varying SI profile, while random deviations of up to 40% were allowed. Simulations were compared with experimental data. The integrated area above the basal glucose curve values were 2.60±0.91 (B), 1.38±0.91 (L), and 1.44±1.07 (D) 104 min·mg/dL in silico versus 2.87±1.65 (B), 1.98±1.56 (L), and 2.16±2.00 (D) 104 min·mg/dL in vivo. Incremental peak glucose values were 109±33 (B), 80±29 (L), and 81±30 (D) mg/dL in silico versus 136±39 (B), 126±37 (L), and 125±48 (D) mg/dL in vivo. The incorporation of a time-varying SI into the simulator makes this technology suitable for running multiple-meal scenarios, thus enabling a more robust design of artificial pancreas algorithms.

AB - Closed-loop control clinical research trials have been considerably accelerated by in silico trials using the Food and Drug Administration-accepted type 1 diabetes mellitus (T1DM) simulator. We have recently demonstrated that postprandial insulin sensitivity (SI) in T1DM subjects was lower at breakfast (B) than lunch (L) and dinner (D), but not significantly, because of the small population size. The goal of this study was therefore to incorporate this novel information into the University of Virginia/Padova T1DM simulator and to reproduce in silico the observed circadian variability. Twenty T1DM subjects received an identical mixed meal at B, L, and D. SI was calculated for each meal using the oral glucose minimal model. Seven SI daily patterns were identified, and their probabilities were estimated. Each in silico subject was linked to a time-varying SI profile, while random deviations of up to 40% were allowed. Simulations were compared with experimental data. The integrated area above the basal glucose curve values were 2.60±0.91 (B), 1.38±0.91 (L), and 1.44±1.07 (D) 104 min·mg/dL in silico versus 2.87±1.65 (B), 1.98±1.56 (L), and 2.16±2.00 (D) 104 min·mg/dL in vivo. Incremental peak glucose values were 109±33 (B), 80±29 (L), and 81±30 (D) mg/dL in silico versus 136±39 (B), 126±37 (L), and 125±48 (D) mg/dL in vivo. The incorporation of a time-varying SI into the simulator makes this technology suitable for running multiple-meal scenarios, thus enabling a more robust design of artificial pancreas algorithms.

UR - http://www.scopus.com/inward/record.url?scp=84920842830&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84920842830&partnerID=8YFLogxK

U2 - 10.1089/dia.2014.0192

DO - 10.1089/dia.2014.0192

M3 - Article

C2 - 25531427

AN - SCOPUS:84920842830

VL - 17

SP - 1

EP - 7

JO - Diabetes Technology and Therapeutics

JF - Diabetes Technology and Therapeutics

SN - 1520-9156

IS - 1

ER -